Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Short-term Investments (2016 - 2017)

Dexcom (DXCM) has disclosed Short-term Investments for 8 consecutive years, with $107.1 million as the latest value for Q4 2017.

  • On a quarterly basis, Short-term Investments rose 266.78% to $107.1 million in Q4 2017 year-over-year; TTM through Dec 2017 was $107.1 million, a 266.78% increase, with the full-year FY2017 number at $107.1 million, up 266.78% from a year prior.
  • Short-term Investments was $107.1 million for Q4 2017 at Dexcom, down from $123.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $123.7 million in Q3 2017 to a low of $11.4 million in Q4 2013.
  • A 5-year average of $41.2 million and a median of $28.8 million in 2015 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: tumbled 71.92% in 2013, then soared 317.91% in 2017.
  • Dexcom's Short-term Investments stood at $11.4 million in 2013, then increased by 3.51% to $11.8 million in 2014, then soared by 146.61% to $29.1 million in 2015, then increased by 0.34% to $29.2 million in 2016, then soared by 266.78% to $107.1 million in 2017.
  • Per Business Quant, the three most recent readings for DXCM's Short-term Investments are $107.1 million (Q4 2017), $123.7 million (Q3 2017), and $100.7 million (Q2 2017).